Linaclotide

CAS No.: 851199-59-2

Linaclotide Chemical Structure

Molecular formula: C₅₉H₇₉N1₅O₂₁S₆

Molecular weight:1526.736

Patent period: —

Dositive specifications:–

Injection : —

Oral tablets: —

Injection: —

Get in touch Download

Products are for laboratory research use only. Not for human use. We do not sell to patients.

Biological Activity

Linaclotide is a potent and selective guanylate cyclase C agonist; Developed for the treatment of constipation-type irritable bowel syndrome (IBS-C) and chronic constipation.

_ LINACLOTIDE

_ LINZEESS

Chemical Properties

ACTIONS	—
CAS NO.	851199-59-2
FORMULA	C₅₉H₇₉N1₅O₂₁S₆
M. WT	1526.736
PURITY	> 98%
SYNONYMS	Linzees
STORAGE	—

Online Inquiry

NASH

The number of patients with non -alcoholic fatty liver patients around the world is on a rise, from 1.55 billion people in 2016 to 1.76 billion in 2020, with a compound annual growth rate of 3.1%;

Other Drug Peptide More+

Tesamorelin

EGRIFTA is a growth hormone releasing factor (GRF) analogindicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy:
Linaclotide new

Linaclotide is a potent and selective guanylate cyclase C agonist; Developed for the treatment of constipation-type irritable bowel syndrome (IBS-C) and chronic constipation.
Thymalfasin

Thymalfasin is a chemically synthesized version of thymosin alpha 1 that is identical to human thymosin alpha 1. Thymosin alpha 1 is an acetylated polypeptide.

Product Catalog